| JDERX | PAMCX | JDERX / PAMCX | |
| Total Expense Ratio | 1.26 | 1.01 | 125% |
| Annual Report Gross Expense Ratio | 1.51 | 1.01 | 150% |
| Fund Existence | 20 years | 26 years | - |
| Gain YTD | 1.806 | 3.012 | 60% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.17B | 25.9B | 8% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -9.02 | -9.58 | 94% |
| Returns for 3 years | 13.76 | 8.23 | 167% |
| Returns for 5 years | -51.92 | -8.85 | 587% |
| Returns for 10 years | -65.36 | 25.34 | -258% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JAGLX | 80.79 | 0.72 | +0.90% |
| Janus Henderson Global Life Sciences T | |||
| MAGRX | 33.94 | 0.26 | +0.77% |
| BlackRock Natural Resources Instl | |||
| ICEIX | 25.61 | 0.16 | +0.63% |
| Macquarie International Core Eq I | |||
| MSOIX | 37.87 | 0.17 | +0.45% |
| NYLI WMC Enduring Capital Class I | |||
| CISAX | 8.71 | 0.03 | +0.35% |
| Copeland International Small Cap A | |||